78065-00-6

Basic information

• Product Name: 1-(1-(4-broMophenyl)ethyl)pyrrolidine
• Synonyms: 1-(1-(4-broMophenyl)ethyl)pyrrolidine
• CAS NO: 78065-00-6
• Molecular Formula: C₁₂H₁₆BrN
• Molecular Weight: 254.16614
• Mol File: 78065-00-6.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(1-(4-broMophenyl)ethyl)pyrrolidine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(1-(4-broMophenyl)ethyl)pyrrolidine(78065-00-6)
• EPA Substance Registry System: 1-(1-(4-broMophenyl)ethyl)pyrrolidine(78065-00-6)

Safety Data

• Hazardous Substances Data: 78065-00-6(Hazardous Substances Data)

Usage

General Description

1-(1-(4-bromophenyl)ethyl)pyrrolidine is a chemical compound with the molecular formula C14H20BrN. It is a member of the pyrrolidine family of compounds and contains a bromine atom attached to a phenyl ring, and an ethyl group attached to a pyrrolidine ring. 1-(1-(4-broMophenyl)ethyl)pyrrolidine is used in organic synthesis and pharmaceutical research, and it may have potential applications in the development of new drugs or other biologically active compounds. Its structure and properties make it a versatile building block for producing a wide variety of chemical derivatives with potential uses in medicinal chemistry, agriculture, and other fields.

Upstream product

• 123-75-1 pyrrolidine 
• 99-90-1 para-bromoacetophenone 

Downstream Products

• 1293917-82-4 1-[1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethyl]pyrrolidine 
• 2254409-25-9 C₂₈H₂₇N₅O₂S 

Relevant articles and documents

NAPHTHYRIDINE DERIVATIVES AS PRC2 INHIBITORS

Disclosed are compounds of formula (I) or (II) that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

PRC2 INHIBITORS

The present invention relates to compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention. (Formula (I))

PYRIDINYLQUINAZ0LINAMINE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS

The invention relates to chemical compounds of the formula (I) or pharmaceutically acceptable salts thereof, which possess B-Raf inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.